Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MULTI 12 INJECTION 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG LIQUID Resolved 2023-04-20 2023-05-03 189913
MULTI-12/K1 PEDIATRIC 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG 400UNIT 2300UNIT 80MG LIQUID Resolved 2024-01-08 2024-02-06 215358
MULTI-12/K1 PEDIATRIC 400UNIT 2300UNIT 80MG 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG LIQUID Resolved 2021-11-04 2022-01-21 148846
MULTI-12/K1 PEDIATRIC 400UNIT 2300UNIT 80MG 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG LIQUID Resolved 2022-10-25 2023-05-30 172557
MYCAMINE 50MG POWDER FOR SOLUTION Resolved 2025-02-11 2025-04-08 250175
NALOXONE HCL INJECTION - 0.4MG/ML USP 0.4MG LIQUID Resolved 2017-03-21 2017-04-12 3820
NALOXONE HCL INJECTION - 0.4MG/ML USP 0.4MG LIQUID Avoided shortage 2017-03-21 2017-06-26 3823
NALOXONE HCL INJECTION - 0.4MG/ML USP 0.4MG LIQUID Resolved 2022-03-10 2022-04-06 156432
NALOXONE HCL INJECTION - 0.4MG/ML USP 0.4MG LIQUID Resolved 2019-04-05 2019-07-08 80570
NALOXONE HCL INJECTION - 1MG/ML USP 1MG LIQUID Resolved 2023-01-19 2023-03-21 181704
NALOXONE HCL INJECTION - 1MG/ML USP 1MG LIQUID Resolved 2020-12-07 2021-02-16 129727
NALOXONE HCL INJECTION - 1MG/ML USP 1MG LIQUID Resolved 2022-10-19 2022-12-29 172174
NALOXONE HCL INJECTION - 1MG/ML USP 1mg/mL INJ Resolved 2017-03-14 2017-06-26 2609
NALOXONE HCL INJECTION - 1MG/ML USP 1MG LIQUID Resolved 2019-04-05 2019-06-28 80573
NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP 1MG LIQUID Resolved 2018-01-08 2018-01-18 35329
NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP 1MG LIQUID Resolved 2022-04-20 2022-10-13 159100
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Resolved 2020-06-08 2023-11-17 116949
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Resolved 2018-01-18 2018-02-05 36548
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Resolved 2017-05-30 2017-10-18 11488
OMEP 20MG CAPSULE (DELAYED RELEASE) Resolved 2017-09-07 2017-10-25 21295
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ RANITIDINE 150MG TABLET Reversed 2020-06-17 2020-06-17 118175
SANDOZ RISPERIDONE 0.5MG TABLET Discontinued 2025-12-01 2025-12-02 272923
SANDOZ RISPERIDONE 3MG TABLET Discontinued 2026-04-15 2026-04-15 282885
SANDOZ RISPERIDONE 2MG TABLET Discontinued 2026-04-15 2026-04-15 282907
SANDOZ RISPERIDONE 2MG TABLET Discontinued 2026-04-15 2026-04-15 282904
SANDOZ RISPERIDONE 1MG TABLET Discontinued 2026-04-15 2026-04-15 282901
SANDOZ RISPERIDONE 3MG TABLET Discontinued 2026-04-15 2026-04-15 282882
SANDOZ RISPERIDONE 3.0MG TABLET Discontinued 2021-03-22 2021-03-22 136095
SANDOZ RISPERIDONE 1.0MG TABLET Discontinued 2021-08-19 2021-08-19 144338
SANDOZ RISPERIDONE 1MG TABLET Discontinued 2025-07-02 2025-07-03 261506
SANDOZ RISPERIDONE 0.25MG TABLET Discontinued 2026-04-15 2026-04-15 282898
SANDOZ RISPERIDONE 4MG TABLET Discontinued 2026-04-15 2026-04-15 282918
SANDOZ RIVASTIGMINE 6MG CAPSULE Discontinued 2025-06-25 2025-06-26 261105
SANDOZ RIVASTIGMINE 6MG CAPSULE Discontinued 2024-12-10 2024-12-11 245291
SANDOZ RIVASTIGMINE 1.5MG CAPSULE Discontinued 2024-12-10 2024-12-11 245288
SANDOZ RIVASTIGMINE 1.5MG CAPSULE Discontinued 2024-12-10 2024-12-11 245285
SANDOZ RIVASTIGMINE 4.5MG CAPSULE Discontinued 2024-12-10 2024-12-11 245282
SANDOZ RIVASTIGMINE 4.5MG CAPSULE Discontinued 2024-12-10 2024-12-11 245279
SANDOZ RIVASTIGMINE 3MG CAPSULE Discontinued 2024-12-10 2024-12-11 245276
SANDOZ RIVASTIGMINE 3MG CAPSULE Discontinued 2024-12-10 2024-12-11 245273

Showing 101 to 120 of 136